Danaher Completes Tender Offer for Beckman Coulter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher reported after the close of the market on Friday that it's wholly owned subsidiary Djanet Acqusition has completed its tender offer for Beckman Coulter for $83.50 per share.

Separately, Danaher also said that it has issued a total of $1.1 billion in short-term promissory notes to finance part of the $6.8 billion deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.